Danske Bank’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.8K Hold
400
﹤0.01% 861
2026
Q1
$7.69K Sell
400
-1,200
-75% -$23.6K ﹤0.01% 844
2025
Q4
$30.3K Hold
1,600
﹤0.01% 1113
2025
Q3
$29.8K Hold
1,600
﹤0.01% 1103
2025
Q2
$29.5K Buy
1,600
+800
+100% +$14.2K ﹤0.01% 1121
2025
Q1
$14K Hold
800
﹤0.01% 1025
2024
Q4
$13.9K Sell
800
-3,900
-83% -$71.2K ﹤0.01% 1050
2024
Q3
$87.5K Buy
4,700
+2,700
+135% +$45.5K ﹤0.01% 1047
2024
Q2
$30.8K Buy
+2,000
New +$28.6K ﹤0.01% 1021

Other funds holding SBRA

Danske Bank's SBRA Position: Q2 2026 in Review

Danske Bank held its Sabra Healthcare REIT (SBRA) position steady in Q2 2026 at 400 shares worth $7.8K. The position accounts for ﹤0.01% of the portfolio, ranked #861.

Danske Bank first reported a position in SBRA in Q2 2024 and has held it in 9 quarters since. The position peaked at $87.5K in Q3 2024. 358 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Danske Bank held 400 shares of Sabra Healthcare REIT worth $7.8K as of Q2 2026.
  • Danske Bank left its Sabra Healthcare REIT share count unchanged in Q2 2026.
  • Sabra Healthcare REIT made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #861 holding.
  • Danske Bank first reported a position in Sabra Healthcare REIT in Q2 2024 and has held it in 9 quarters since.
  • Danske Bank's Sabra Healthcare REIT position peaked at $87.5K in Q3 2024.
  • 358 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.